Follow us Facebook Icon

24 January 2023

Serum Institute Of India launches the first made-in-India qHPV vaccine 'CERVAVAC'

Hon'ble Union Home Minister Shri Amit Shah launches the first made-in-India qHPV vaccine 'CERVAVAC' along with SII CEO Adar Poonawalla and SII Director Prakash Kumar Singh.

Hon'ble Union Home Minister Shri Amit Shah launches the first made-in-India qHPV vaccine 'CERVAVAC' along with SII CEO Adar Poonawalla and SII Director Prakash Kumar Singh.

On the occasion of India's National Girl Child Day and Cervical Cancer Awareness Month, Serum Institute Of India is pleased to launch the first made-in-India qHPV vaccine 'CERVAVAC' by the hands of our Hon'ble Home Minister Shri Amit Shah at New Delhi on 24 January 2023.

India’s first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) ‘CERVAVAC’ is an outcome of a partnership between Serum Institute Of India (SII), Department of Biotechnology (DBT) and the Biotechnology Industry Research Assistance Council (BIRAC) along with the Bill and Melinda Gates Foundation.

Hon'ble Union Home Minister Shri Amit Shah, SII CEO Adar Poonawalla and SII Director Prakash Kumar Singh

L-R Hon'ble Union Home Minister Shri Amit Shah, SII CEO Adar Poonawalla and SII Director Prakash Kumar Singh

Hon'ble Health Minister Dr. Mansukh Mandaviya being presented with the made-in-India qHPV vaccine 'Cervavac' by SII CEO Adar Poonawalla and SII Director Prakash Kumar Singh

Hon'ble Health Minister Dr. Mansukh Mandaviya being presented with the made-in-India qHPV vaccine 'Cervavac' by SII CEO Adar Poonawalla and SII Director Prakash Kumar Singh

Dr. Jitendra Singh, Hon'ble Minister of State of the Ministry of Science and Technology & Earth Sciences being presented with the made-in-India qHPV vaccine 'Cervavac' by SII Director Prakash Kumar Singh.

Dr. Jitendra Singh, Hon'ble Minister of State of the Ministry of Science and Technology & Earth Sciences being presented with the made-in-India qHPV vaccine 'Cervavac' by SII Director Prakash Kumar Singh.